16-69933104-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_001270454.2(WWP2):c.1683-866A>G variant causes a intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
WWP2
NM_001270454.2 intron
NM_001270454.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 8.81
Genes affected
WWP2 (HGNC:16804): (WW domain containing E3 ubiquitin protein ligase 2) This gene encodes a member of the Nedd4 family of E3 ligases, which play an important role in protein ubiquitination. The encoded protein contains four WW domains and may play a role in multiple processes including chondrogenesis and the regulation of oncogenic signaling pathways via interactions with Smad proteins and the tumor suppressor PTEN. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 10. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-69933104-A-G is Pathogenic according to our data. Variant chr16-69933104-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 599186.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWP2 | NM_001270454.2 | c.1683-866A>G | intron_variant | ENST00000359154.7 | NP_001257383.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWP2 | ENST00000359154.7 | c.1683-866A>G | intron_variant | 1 | NM_001270454.2 | ENSP00000352069.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 356244Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 201594
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
356244
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
201594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Spondyloepiphyseal dysplasia MIR140 type Nishimura Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Rare Disease Group, Clinical Genetics, Karolinska Institutet | Aug 01, 2017 | This variant causes a novel skeletal dysplasia. It has been identified in three patients. Two of them are not related. Functional studies on transgenic mice confirmed its pathogenicity. - |
Spondyloepiphyseal dysplasia, nishimura type Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 09, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at